Title: China's Artificial Interferon Research Reaches International Level
Author: Zhang Xuequan
Date: 1989-12-26
Edition: 1

    China's scientists have recently completed research on the gene engineering of human (gamma) interferon, achieving a laboratory pure product yield far superior to similar international studies, reaching an internationally leading level.

    Using gene engineering methods to synthesize human (gamma) interferon has the advantages of high yield and low cost compared to natural induction methods for obtaining interferon, making it a hot topic in the international scientific community. However, the expression yield of some countries conducting this research is only 30% to 40% of the total bacterial protein. China has now reached over 60%. This creates favorable conditions for the research results to enter industrialized production and achieve high efficiency.

    Scientific experiments have proven that human (gamma) interferon, in addition to its antiviral and cell growth inhibitory activities, primarily acts on the immune system. It has varying degrees of therapeutic effects on renal cell carcinoma, small cell lung cancer, colon cancer, melanoma, leishmaniasis, rheumatoid arthritis, genital warts, and other viral diseases.


<hr /> 

Original: 


### 我人工干扰素研究创国际水平
张学全
1989-12-26
第1版(要闻)
专栏：

    我人工干扰素研究创国际水平
    据新华社上海电　（记者张学全）我国科学家新近完成的人（伽玛）型干扰素基因工程研究，以实验室纯品产率远远高于国外同类研究的结果，创造出国际领先水平。
    用基因工程方法合成人（伽玛）型干扰素，因比天然诱导法获取干扰素有着产量大、成本低的优点，从而成为国际科技界的热门课题。但一些国家进行这项研究的表达产率，只占菌体总蛋白的30％至40％，我国现已达到60％以上。这为研究成果进入工业化生产获取高效益创造了有利条件。
    科学实验证明，人（伽玛）型干扰素除有抗病毒和抑制细胞生长活性外，主要对免疫系统产生作用，它对肾细胞癌、小细胞肺癌、结肠癌、黑色素瘤、利什曼黑热病、风湿性关节炎、性器官疣及其它病毒性疾病，均有不同程度的疗效。
